Acadia Healthcare (NASDAQ:ACHC) Releases Quarterly Earnings Results

Acadia Healthcare (NASDAQ:ACHC) issued its quarterly earnings results on Wednesday. The company reported $0.60 EPS for the quarter, beating analysts’ consensus estimates of $0.46 by $0.14, FiscalAI reports. The company had revenue of $895.31 million for the quarter, compared to analyst estimates of $877.76 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%. The company’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.72 earnings per share.

Acadia Healthcare Stock Performance

Shares of NASDAQ:ACHC traded up $4.01 during trading on Thursday, reaching $36.26. 520,301 shares of the stock were exchanged, compared to its average volume of 2,812,781. Acadia Healthcare has a 12 month low of $11.43 and a 12 month high of $39.38. The stock has a 50-day moving average price of $29.18 and a 200-day moving average price of $25.91. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20. The firm has a market cap of $3.38 billion, a PE ratio of -2.91, a PEG ratio of 9.54 and a beta of 0.64.

More Acadia Healthcare News

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Acadia reported third-quarter adjusted earnings of $0.60 per share, ahead of the $0.46 consensus estimate, and revenue of $895.3 million versus expectations of $877.8 million. Revenue increased 5.1% year over year. Read More.
• Positive Sentiment: The company raised its full-year 2026 financial guidance, with its outlook described as slightly above expectations. Same-facility revenue grew 5.2%, supported by a 1.1% increase in patient days and 4.0% growth in revenue per patient day. Read More.
• Negative Sentiment: Despite beating analysts’ estimates, quarterly EPS was down from $0.72 a year earlier, a year-over-year comparison that tempers the otherwise favorable results. Read More.

Analysts Set New Price Targets

ACHC has been the topic of a number of recent research reports. Barclays lifted their target price on Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a research report on Thursday, July 30th. Guggenheim upped their target price on Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday, July 30th. KeyCorp boosted their price target on Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 14th. Cantor Fitzgerald reiterated a “neutral” rating on shares of Acadia Healthcare in a research note on Tuesday, October 6th. Finally, TD Cowen increased their price objective on Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Eight equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $30.69.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.

Acadia’s services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.

Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.